Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Tongyuan Pharmaceutical Group is a comprehensive pharmaceutical enterprise based in Chengdu, China, specializing in the research, development, production, and distribution of medicinal products. The company's portfolio includes Traditional Chinese Medicines (TCM), chemical drugs, and health supplements, with a strong focus on therapeutic areas such as respiratory health, cardiovascular conditions, and digestive disorders. Operating through multiple subsidiaries, the group maintains modern manufacturing facilities that adhere to strict GMP standards for various dosage forms including oral liquids, tablets, and capsules. Tongyuan is recognized for its integrated supply chain, spanning from raw material cultivation to finished product sales in the domestic Chinese market. The company is a significant regional player in the Sichuan pharmaceutical industry and is known for its flagship respiratory products like Compound Licorice Oral Solution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Tongyuan Pharmaceutical Group.